Report Summary
Eternity Insights has published a new study on Global Artificial Pancreas Devices Systems Market focusing on key segments as by Type (Threshold Suspend Device System,Non-Threshold Suspend Device System (NTSDS),Control to Range System (CTRS),Control to Target System (CTTS)), by Application (Hospitals,Clinics,Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Artificial Pancreas Devices Systems Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Artificial Pancreas Devices Systems Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Artificial Pancreas Devices Systems Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Artificial Pancreas Devices Systems Market Segmentation:
Artificial Pancreas Devices Systems Market, By Type
- Threshold Suspend Device System
- Non-Threshold Suspend Device System (NTSDS)
- Control to Range System (CTRS)
- Control to Target System (CTTS)
Artificial Pancreas Devices Systems Market, By Application
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Artificial Pancreas Devices Systems market in terms of demand generation. The Artificial Pancreas Devices Systems market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Artificial Pancreas Devices Systems market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Artificial Pancreas Devices Systems Market Taxonomy:
To learn more about this report
Global Artificial Pancreas Devices Systems Market Competitive Landscape
The global Artificial Pancreas Devices Systems market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Medtronic
- Johnson & Johnson
- Roche
- Insulet
- Tandem Diabetes Care
- Inreda Diabetic
- Dexcom
- TypeZero Technologies
- Cellnovo Group
- Beta Bionics
- Bigfoot Biomedical
- DreaMed Diabetes
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Threshold Suspend Device System,Non-Threshold Suspend Device System (NTSDS),Control to Range System (CTRS),Control to Target System (CTTS) |
| By Application Outlook |
Hospitals,Clinics,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Medtronic,Johnson & Johnson,Roche,Insulet,Tandem Diabetes Care,Inreda Diabetic,Dexcom,TypeZero Technologies,Cellnovo Group,Beta Bionics,Bigfoot Biomedical,DreaMed Diabetes |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Artificial Pancreas Devices Systems Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Artificial Pancreas Devices Systems Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Threshold Suspend Device System Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Non-Threshold Suspend Device System (NTSDS) Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Control to Range System (CTRS) Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Control to Target System (CTTS) Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Artificial Pancreas Devices Systems Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Artificial Pancreas Devices Systems Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Artificial Pancreas Devices Systems Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Artificial Pancreas Devices Systems Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Artificial Pancreas Devices Systems Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Artificial Pancreas Devices Systems Market Assessment by Type
8.1 Asia Pacific Artificial Pancreas Devices Systems Market Assessment by Application (Consumption and Market Share)
8.2 North America Artificial Pancreas Devices Systems Market Assessment by Application (Consumption and Market Share)
8.3 Europe Artificial Pancreas Devices Systems Market Assessment by Application (Consumption and Market Share)
8.4 South America Artificial Pancreas Devices Systems Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Artificial Pancreas Devices Systems Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Medtronic
9.1.1 Medtronic Profiles
9.1.2 Medtronic Product Portfolio
9.1.3 Medtronic Artificial Pancreas Devices Systems Business Performance
9.1.4 Medtronic Artificial Pancreas Devices Systems Business Development and Market Status
9.2 Johnson & Johnson
9.2.1 Johnson & Johnson Profiles
9.2.2 Johnson & Johnson Product Portfolio
9.2.3 Johnson & Johnson Artificial Pancreas Devices Systems Business Performance
9.2.4 Johnson & Johnson Artificial Pancreas Devices Systems Business Development and Market Status
9.3 Roche
9.3.1 Roche Profiles
9.3.2 Roche Product Portfolio
9.3.3 Roche Artificial Pancreas Devices Systems Business Performance
9.3.4 Roche Artificial Pancreas Devices Systems Business Development and Market Status
9.4 Insulet
9.4.1 Insulet Profiles
9.4.2 Insulet Product Portfolio
9.4.3 Insulet Artificial Pancreas Devices Systems Business Performance
9.4.4 Insulet Artificial Pancreas Devices Systems Business Development and Market Status
9.5 Tandem Diabetes Care
9.5.1 Tandem Diabetes Care Profiles
9.5.2 Tandem Diabetes Care Product Portfolio
9.5.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Business Performance
9.5.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Business Development and Market Status
9.6 Inreda Diabetic
9.6.1 Inreda Diabetic Profiles
9.6.2 Inreda Diabetic Product Portfolio
9.6.3 Inreda Diabetic Artificial Pancreas Devices Systems Business Performance
9.6.4 Inreda Diabetic Artificial Pancreas Devices Systems Business Development and Market Status
9.7 Dexcom
9.7.1 Dexcom Profiles
9.7.2 Dexcom Product Portfolio
9.7.3 Dexcom Artificial Pancreas Devices Systems Business Performance
9.7.4 Dexcom Artificial Pancreas Devices Systems Business Development and Market Status
9.8 TypeZero Technologies
9.8.1 TypeZero Technologies Profiles
9.8.2 TypeZero Technologies Product Portfolio
9.8.3 TypeZero Technologies Artificial Pancreas Devices Systems Business Performance
9.8.4 TypeZero Technologies Artificial Pancreas Devices Systems Business Development and Market Status
9.9 Cellnovo Group
9.9.1 Cellnovo Group Profiles
9.9.2 Cellnovo Group Product Portfolio
9.9.3 Cellnovo Group Artificial Pancreas Devices Systems Business Performance
9.9.4 Cellnovo Group Artificial Pancreas Devices Systems Business Development and Market Status
9.10 Beta Bionics
9.10.1 Beta Bionics Profiles
9.10.2 Beta Bionics Product Portfolio
9.10.3 Beta Bionics Artificial Pancreas Devices Systems Business Performance
9.10.4 Beta Bionics Artificial Pancreas Devices Systems Business Development and Market Status
9.11 Bigfoot Biomedical
9.12 DreaMed Diabetes
10 World Artificial Pancreas Devices Systems Market Assessment by Players
10.1 Global Artificial Pancreas Devices Systems Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Artificial Pancreas Devices Systems Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Artificial Pancreas Devices Systems Price (USD/Unit) of Players 2014-2020
10.4 Global Artificial Pancreas Devices Systems Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Artificial Pancreas Devices Systems Sales Assessment of Players 2014-2020
11.1.2 North America Artificial Pancreas Devices Systems Revenue Assessment of Players 2014-2020
11.1.3 North America Artificial Pancreas Devices Systems Price Assessment of Players 2014-2020
11.1.4 North America Artificial Pancreas Devices Systems Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Artificial Pancreas Devices Systems Sales Assessment of Players 2014-2020
11.2.2 Europe Artificial Pancreas Devices Systems Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Artificial Pancreas Devices Systems Price Assessment of Players 2014-2020
11.2.4 Europe Artificial Pancreas Devices Systems Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Artificial Pancreas Devices Systems Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Artificial Pancreas Devices Systems Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Artificial Pancreas Devices Systems Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Artificial Pancreas Devices Systems Sales Assessment of Players 2014-2020
11.4.2 South America Artificial Pancreas Devices Systems Revenue Assessment of Players 2014-2020
11.4.3 South America Artificial Pancreas Devices Systems Price Assessment of Players 2014-2020
11.4.4 South America Artificial Pancreas Devices Systems Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Artificial Pancreas Devices Systems Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Artificial Pancreas Devices Systems Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Artificial Pancreas Devices Systems Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Artificial Pancreas Devices Systems Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Artificial Pancreas Devices Systems Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Artificial Pancreas Devices Systems Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Artificial Pancreas Devices Systems Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Artificial Pancreas Devices Systems Sales by Countries/Regions 2014-2020
12.2.2 North America Artificial Pancreas Devices Systems Revenue by Countries/Regions 2014-2020
12.2.3 North America Artificial Pancreas Devices Systems Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Artificial Pancreas Devices Systems Sales by Countries/Regions 2014-2020
12.3.2 Europe Artificial Pancreas Devices Systems Revenue by Countries/Regions 2014-2020
12.3.3 Europe Artificial Pancreas Devices Systems Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Artificial Pancreas Devices Systems Sales by Countries/Regions 2014-2020
12.4.2 South America Artificial Pancreas Devices Systems Revenue by Countries/Regions 2014-2020
12.4.3 South America Artificial Pancreas Devices Systems Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Artificial Pancreas Devices Systems Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Artificial Pancreas Devices Systems Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Artificial Pancreas Devices Systems Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Artificial Pancreas Devices Systems Sales & Revenue Forecast 2021-2026
14.1 World Artificial Pancreas Devices Systems Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Artificial Pancreas Devices SystemsSales and Market Share by Regions
14.1.2 World Artificial Pancreas Devices SystemsRevenue and Market Share by Regions
15 Asia Artificial Pancreas Devices Systems Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Threshold Suspend Device System
15.1.2 Non-Threshold Suspend Device System (NTSDS)
15.1.3 Control to Range System (CTRS)
15.1.4 Control to Target System (CTTS)
15.2 Consumption Forecast by Application, 2021-2026
16 North America Artificial Pancreas Devices Systems Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Threshold Suspend Device System
16.1.2 Non-Threshold Suspend Device System (NTSDS)
16.1.3 Control to Range System (CTRS)
16.1.4 Control to Target System (CTTS)
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Artificial Pancreas Devices Systems Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Threshold Suspend Device System
17.1.2 Non-Threshold Suspend Device System (NTSDS)
17.1.3 Control to Range System (CTRS)
17.1.4 Control to Target System (CTTS)
17.2 Consumption Forecast by Application, 2021-2026
18 South America Artificial Pancreas Devices Systems Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Threshold Suspend Device System
18.1.2 Non-Threshold Suspend Device System (NTSDS)
18.1.3 Control to Range System (CTRS)
18.1.4 Control to Target System (CTTS)
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Artificial Pancreas Devices Systems Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Threshold Suspend Device System
19.1.2 Non-Threshold Suspend Device System (NTSDS)
19.1.3 Control to Range System (CTRS)
19.1.4 Control to Target System (CTTS)
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Artificial Pancreas Devices Systems Price (USD/Unit) Trend 2021-2026
20.2 Global Artificial Pancreas Devices Systems Gross Profit Trend 2021-2026
21 Conclusion
